Research

Displaying 1 - 10 of 234 Articles
MS Ireland
23 Jul 2021

Love Home Swap Survey

Love Home Swap is currently looking for participants to help them in a research project that will open the doors to better holiday options for people with accessibility needs.

MS Ireland Logo
MS Ireland
22 Jul 2021

World Brain Day 2021

World Brain Day 2021 is dedicated to multiple sclerosis (MS), a neurological disease that affects 2.8 million people of all ages globally. Disease-modifying treatments slow the progression of MS, yet access to these medications is unavailable in many parts of the world. 

MS Ireland Logo
MS Ireland
20 Jul 2021

World Brain Day 2021

The MS International Federation is delighted to be partnering with the World Federation of Neurology (WFN) this year on World Brain Day. The 2021 theme is Stop Multiple Sclerosis.

As part of the 2021 World Brain Day campaign, the WFN and MSIF are inviting those with multiple sclerosis, their loved ones, healthcare professionals, multiple sclerosis organisations and everyone else to join in to raise awareness to stop multiple sclerosis through the use of the hashtag #WorldBrainDay2021.

 

MS Ireland Logo
MS Ireland
06 Jul 2021

Prof. Alan Thompson Charcot Award

MS Ireland would like to congratulate Prof. Alan Thompson on winning the 2021 Charcot Award. The Charcot Award recognises a lifetime achievement in outstanding research into understanding and treating MS.  Prof. Thompson who is the Dean of the Faculty of Brain Sciences at UCL in the UK, is a long-time supporter of MS Ireland who has focused his 40-year career on the care and treatment of people living with MS.

MS Ireland Logo
MS Ireland
19 Apr 2021

Tysabri Injections licensed in Europe

The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.

MS Ireland Logo
MS Ireland
30 Mar 2021

Octopus Trial for progressive MS

UK experts are set to run a multi-arm, multi-stage trial which will test a range of drugs already approved for other illnesses for the treatment of multiple sclerosis (MS). The ‘Octopus trial’ will allow three drugs to be tested at the same time.

Top